Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Mathanga, Don P ^a   Chinkhumba, J ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIRETROVIRUS AGENT; CHLOROQUINE; COTRIMOXAZOLE; FANSIDAR; HEMOGLOBIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; MALARIA; MIXED INFECTION; MORTALITY; NUTRITIONAL COUNSELING; NUTRITIONAL SUPPORT; PARASITEMIA; PLASMODIUM FALCIPARUM; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; PRIMARY PREVENTION; REVIEW; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

EID: 44949253178     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006689     Document Type: Review

References (20)

1. Ayisi 2003 Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otioeno JA, Misore AO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003;17(4):585-94.
2. Brahmbhatt 2003 Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Sewankambo N, Lutalo T, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003;17(17):2539-41.
3. Dabis 2002 Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002;359(9323):2097-104.
4. French 2001 French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001;15(7):899-906.
5. Garner 2006 Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD000169. DOI:10.1002/14651858.CD000169.pub2.
6. Grimwade 2003 Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. Childhood malaria in a region of unstable transmission and high immunodeficiency virus prevalence. Pediatric Infectious Disease Journal 2003;22(12):1057-63.
7. Higgins 2006 Higgins JPT, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b. www.cochrane.org/resources/ handbook/hbook.htm (accessed 29 April 2007).
8. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
9. Khasnis 2003 Khasnis AA, Karnad DR. Human immunodeficiency virus type 1 infection in patients with severe falciparum malaria in urban India. Journal of Postgraduate Medicine 2003;49(2):114-7.
10. Korenromp 2005 Korenromp E, for the RBM Monitoring and Evaluation Reference Group & MERG Task Force on Malaria Morbidity. Malaria incidence estimates at country level for the year 2004 - Proposed estimates and draft report. www.who.int/malaria/docs/incidence_estimations2.pdf 2005 (accessed on 22 Septermber 2006).
11. Kublin 2005 Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al. Effects of plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005;365(9455):233-40.
12. Parise 1998 Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene 1998;59(5):813-22.
13. Review Manager 4.2 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
14. Steketee 1996 Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, et al. Impairment of a pregnant woman's acquired ability to limit plasmodium falciparum by infection with human immunodeficiency virus type-1. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:42-9.
15. Tagbor 2006 Tagbor H, Bruce J, Browne E, Randal A, Greenwood B, Chandramohan D. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 2006;368(9544):1349-56.
16. ter Kuile 2004 ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, et al. The burden of co-infection with the human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. American Journal of Tropical Medicine and Hygiene 2004;71 Suppl 2:41-5.
17. UNAIDS 2006 United Nations Programme on HIV/AIDS. Overview of the global AIDS Epidemic. 2006 Report on the global AIDS epidemic. UNAIDS, 2006:8-50.
18. Van Geertruyden 2006 Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, et al. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. Journal of Infectious Diseases 2006;194(7):917-25.
19. Whitworth 2000 Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000;356(9235):1051-6.
20. WHO 2004 World Health Organization, Regional Office for Africa. A strategic framework for malaria prevention and control during pregnancy in the African region [AFR/MAL/04/01]. Brazzaville: World Health Organization, 2004.